Noven Provides Update on Daytrana(R) Methylphenidate Transdermal System.
Business Wire › August 25, 2008
Linked as:
Extract
Noven Provides Update on Daytrana(R) Methylphenidate Transdermal System.
Shire Undertakes Voluntary Recall of Two Lots of Daytrana([R]) Product
MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today provided an update on the status of Daytrana([R]), the only transdermal patch indicated for the treatment of the symptoms of Attention Deficit Hyperactivity Disorder (ADHD). Daytrana([R]), developed and manufactured by Noven, ...See the full content of this document
Sponsored links
